March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Myeloma Paper of the Day, February 19th, suggested by Robert Orlowski
Feb 19, 2025, 10:44

Myeloma Paper of the Day, February 19th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Comparison of standard-of-care Ide-cel and Cilta-cel in relapsed/refractory myeloma finds Cilta associated with higher likelihood of grade ≥3 CRS, SPMs, and delayed neurotox, but better treatment responses, PFS, and OS.”

“Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma”

Authors: Doris Hansen et al.

Myeloma Paper of the Day, February 19th, suggested by Robert Orlowski

More posts featuring Robert Orlowski.